Inspire Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	624.8	407.86	233.39	115.38	82.05	50.59	28.57	16.43	8.01
Revenue Growth (YoY)	53.19%	74.75%	102.28%	40.62%	62.18%	77.10%	73.90%	105.03%	-
Cost of Revenue	96.58	66.12	33.28	17.62	13.64	10.06	6.02	3.91	2.81
Gross Profit	528.22	341.74	200.12	97.76	68.41	40.54	22.55	12.52	5.2
Selling, General & Admin	451.96	320.69	202.62	127.87	90.47	53.53	32.36	22.68	17.92
Research & Development	116.54	68.65	37.35	26.09	12.84	7.39	6.19	7.09	7.08
Operating Expenses	568.49	389.33	239.97	153.97	103.3	60.92	38.55	29.78	25
Operating Income	-40.27	-47.59	-39.85	-56.21	-34.9	-20.38	-16	-17.25	-19.8
Interest Expense / Income	0	1.68	2.13	2.12	2.12	3.3	1.75	1.3	1.56
Other Expense / Income	-20.37	-5	-0.01	-1.24	-3.81	-1.85	-0.25	-0.03	-0.03
Pretax Income	-19.91	-44.27	-41.97	-57.09	-33.2	-21.83	-17.51	-18.53	-21.34
Income Tax	1.25	0.61	0.07	0.12	0.04	0	0	0	0
Net Income	-21.15	-44.88	-42.04	-57.2	-33.24	-21.83	-17.51	-18.53	-21.34
Shares Outstanding (Basic)	29	28	27	26	24	15	1	1	1
Shares Outstanding (Diluted)	29	28	27	26	24	15	1	1	1
Shares Change	4.38%	2.97%	4.56%	9.53%	63.27%	1139.08%	7.36%	6.62%	-
EPS (Basic)	-0.72	-1.60	-1.54	-2.19	-1.40	-1.50	-14.88	-16.90	-20.74
EPS (Diluted)	-0.72	-1.60	-1.54	-2.19	-1.40	-1.50	-14.88	-16.90	-20.74
Free Cash Flow	1.02	2.47	-24.79	-55.5	-35.59	-18.94	-16.2	-18.26	-22.6
Free Cash Flow Per Share	0.04	0.09	-0.91	-2.13	-1.50	-1.30	-13.77	-16.66	-21.99
Gross Margin	84.54%	83.79%	85.74%	84.73%	83.37%	80.12%	78.93%	76.23%	64.94%
Operating Margin	-6.45%	-11.67%	-17.07%	-48.72%	-42.53%	-40.28%	-56.02%	-105.03%	-247.10%
Profit Margin	-3.39%	-11.00%	-18.01%	-49.58%	-40.52%	-43.14%	-61.30%	-112.79%	-266.31%
Free Cash Flow Margin	0.16%	0.61%	-10.62%	-48.10%	-43.37%	-37.44%	-56.72%	-111.13%	-282.08%
EBITDA	-15.66	-39.69	-37.85	-53.16	-29.69	-18.13	-15.47	-17.12	-19.65
EBITDA Margin	-2.51%	-9.73%	-16.22%	-46.07%	-36.18%	-35.84%	-54.16%	-104.23%	-245.29%
Depreciation & Amortization	4.25	2.9	1.99	1.81	1.4	0.39	0.29	0.1	0.12
EBIT	-19.91	-42.59	-39.84	-54.97	-31.08	-18.52	-15.76	-17.23	-19.77
EBIT Margin	-3.19%	-10.44%	-17.07%	-47.64%	-37.88%	-36.61%	-55.16%	-104.86%	-246.79%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).